SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-023663
Filing Date
2016-08-09
Accepted
2016-08-09 16:06:48
Documents
62
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q srpt-10q_20160630.htm 10-Q 2311259
2 EX-10.1 srpt-ex101_731.htm EX-10.1 33270
3 EX-31.1 srpt-ex311_6.htm EX-31.1 10567
4 EX-31.2 srpt-ex312_8.htm EX-31.2 10639
5 EX-32.1 srpt-ex321_9.htm EX-32.1 7307
6 EX-32.2 srpt-ex322_7.htm EX-32.2 7329
  Complete submission text file 0001564590-16-023663.txt   6431301

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT srpt-20160630.xml EX-101.INS 1420044
8 XBRL TAXONOMY EXTENSION SCHEMA srpt-20160630.xsd EX-101.SCH 34177
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20160630_cal.xml EX-101.CAL 41596
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20160630_def.xml EX-101.DEF 59032
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20160630_lab.xml EX-101.LAB 229560
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20160630_pre.xml EX-101.PRE 182591
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 161817917
SIC: 2834 Pharmaceutical Preparations